Stock Events

Stock Events

Nutriband

$3.53

0

+$0+0% Tuesday 02:56

Statistics

Day High

3.53

Day Low

3.46

52W High

-

52W Low

-

Volume

240

Avg. Volume

-

Mkt Cap

42.97M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Earnings

1MayExpected

Q3 2025

Next

-2.13

-2.05

-1.97

-1.89

Expected EPS

-1.89

Actual EPS

N/A

Financials

-489.86%Profit Margin

Unprofitable

2019

2020

2021

2022

2023

2024

4.28MRevenue

-20.97MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NTRB.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Johnson & Johnson

Johnson & Johnson operates in the pharmaceutical and consumer health sectors, directly competing with Nutriband's range of health and wellness products.

Pfizer is a global biopharmaceutical company that develops and manufactures drugs and vaccines, including products that could compete with Nutriband's offerings.

Novartis is a healthcare company that provides solutions in various areas, including pharmaceuticals, which can compete with Nutriband's product portfolio.

GlaxoSmithKline is a healthcare company that focuses on pharmaceuticals and consumer healthcare products, competing in similar markets as Nutriband.

AbbVie is a biopharmaceutical company with a wide range of products that compete in the same space as Nutriband's healthcare and wellness products.

Merck & Co., Inc. is a global healthcare company that produces pharmaceuticals and vaccines, competing with Nutriband in the healthcare sector.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company with products that compete across several of Nutriband's key areas of focus.

Amgen is a biotechnology company focused on human therapeutics, with products that could compete with Nutriband's healthcare solutions.

Teva- Pharmaceutical Industries

Teva Pharmaceutical Industries is a global pharmaceutical company that manufactures generic and specialty medicines, competing with Nutriband's product lines.

Eli Lilly and Company is a global pharmaceutical company with a wide range of products that compete with Nutriband in the pharmaceutical and healthcare market.

About

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Show more...

CEO

ISIN

US67092M2089

Listings

0 Comments

Share your thoughts

FAQ

What is Nutriband stock price today?▼

The current price of NTRB.BOATS is $3.53 USD — it has increased by +0% in the past 24 hours. Watch Nutriband stock price performance more closely on the chart.

What is Nutriband stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Nutriband stocks are traded under the ticker NTRB.BOATS.

What is Nutriband market cap?▼

Today Nutriband has the market capitalization of 42.97M

When is the next Nutriband earnings date?▼

Nutriband is going to release the next earnings report on May 01, 2026.

What is Nutriband revenue for the last year?▼

Nutriband revenue for the last year amounts to 4.28M USD.

What is Nutriband net income for the last year?▼

NTRB.BOATS net income for the last year is -20.97M USD.

When did Nutriband complete a stock split?▼

The last stock split for Nutriband was on July 25, 2025 with a ratio of 5:4.